drugset / Trial / NCT02194244

Comparative Bioavailability Study of Film-coated Tablet and Granule Formulations of RG1662

NCT02194244 ↗

Phase 1 Completed 18 enrolled Hoffmann-La Roche
RandomizedCrossoverOpen-label

Summary

This study will compare the pharmacokinetic performance of film-coated tablet and granule formulations of RG1662 under fed and fasted conditions in healthy volunteers. A randomized, four-period, four-treatment crossover design is used. In each period, each volunteer will receive a single oral dose of the tablet or granule formulation either with or without food.

Timeline

Start
2014-08
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Basmisanil Small molecule — Oral

Indications

No indication recorded.